Phase I evaluation of a combination of monoclonal antibody R24 and interleukin 2 in patients with metastatic melanoma (Q68623418)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 December 1990
edit
Language Label Description Also known as
English
Phase I evaluation of a combination of monoclonal antibody R24 and interleukin 2 in patients with metastatic melanoma
scientific article published on 01 December 1990

    Statements

    Phase I evaluation of a combination of monoclonal antibody R24 and interleukin 2 in patients with metastatic melanoma (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit